CytomX Therapeutics Inc (NAS:CTMX)
$ 1.2 0 (0%) Market Cap: 93.74 Mil Enterprise Value: -31.70 Mil PE Ratio: 8.57 PB Ratio: 0 GF Score: 55/100

Full Year 2018 CytomX Therapeutics Inc Earnings Call Transcript

Feb 27, 2019 / 10:00PM GMT
Release Date Price: $12.73 (-3.05%)
Operator

Good afternoon, and welcome to the CytomX 2018 Full Year Financial Results Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded. I'd now like to turn the call over to Chris Keenan, CytomX's Vice President of Investor Relations. You may begin.

Christopher S. Keenan
CytomX Therapeutics, Inc. - VP of IR & Corporate Communications

Good afternoon, and thank you for joining us for our 2018 Full Year Financial Results Conference Call.

Here with me today is CytomX President, Chief Executive Officer and Chairman, Dr. Sean McCarthy; and Debanjan Ray, our Chief Financial Officer.

Before we begin, I would like to remind you that we will be making forward-looking statements during the call. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict and many of which are outside of our control. Important risks and uncertainties are set forth in our most recent public filings with the SEC at sec.gov, including our Form 10

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot